000 01212 a2200325 4500
005 20250516103032.0
264 0 _c20130122
008 201301s 0 0 eng d
022 _a1879-0372
024 7 _a10.1016/j.coi.2012.06.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTurtle, Cameron J
245 0 0 _aEngineered T cells for anti-cancer therapy.
_h[electronic resource]
260 _bCurrent opinion in immunology
_cOct 2012
300 _a633-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aGenetic Engineering
_xmethods
650 0 4 _aHLA Antigens
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xmethods
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
650 0 4 _aTransduction, Genetic
700 1 _aHudecek, Michael
700 1 _aJensen, Michael C
700 1 _aRiddell, Stanley R
773 0 _tCurrent opinion in immunology
_gvol. 24
_gno. 5
_gp. 633-9
856 4 0 _uhttps://doi.org/10.1016/j.coi.2012.06.004
_zAvailable from publisher's website
999 _c21963252
_d21963252